Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Alligator Bioscience Ab patents

Recent patent applications related to Alligator Bioscience Ab. Alligator Bioscience Ab is listed as an Agent/Assignee. Note: Alligator Bioscience Ab may have other listings under different names/spellings. We're not affiliated with Alligator Bioscience Ab, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Alligator Bioscience Ab-related inventors

Novel polypeptides

The present invention provides bispecific polypeptides, such as bispecific antibodies, comprising a first binding domain capable of specifically binding to a first t cell target, and a second binding domain capable of specifically binding to a second t cell target, wherein the first and second t cell targets are different targets. The invention further provides compositions of said bispecific polypeptides, as well as methods and uses of the same. ... Alligator Bioscience Ab

Bispecific molecules capable of specifically binding to both ctla-4 and cd40

The present disclosure relates to bispecific molecules that specifically bind to both cd40 and ctla-4, and in particular to both human cd40 and human ctla-4.. . ... Alligator Bioscience Ab

Anti-cd40 antibodies, uses and methods

The present invention relates to antibodies (and fragments, variants, fusions and derivatives thereof) with multivalent binding specificity for cd40, which have a potency for dendritic cell activation which is higher than, or is equal to, the potency for b cell activation and wherein the antibody, antigen-binding fragment, or fusion, variant or derivative thereof has an affinity (kd) for cd40 of less than 1×10−10 m, which have utility in the treatment of diseases such as cancer. The invention also relates to pharmaceutical compositions, uses, methods and kits comprising such antibodies.. ... Alligator Bioscience Ab

Combination therapies with anti cd40 antibodies

The present invention relates to combination therapies for treating a solid tumour in a subject. The combination therapies comprise (a) an antibody, or antigen-binding portion thereof, that specifically binds to cd40, and (b) a further immunotherapeutic agent with efficacy in the treatment of cancer, which agent is not an anti-cd40 antibody or antigen-binding fragment thereof. ... Alligator Bioscience Ab

Scfv antibody library

The invention provides libraries of antibody molecules, libraries of nucleic acids encoding antibody molecules, methods of producing said libraries, and methods of using said libraries to select an antibody which specifically binds to an antigen. The libraries of antibody molecules include a plurality of different antibody variable domains generated by creating diversity in the cdr regions.. ... Alligator Bioscience Ab

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Alligator Bioscience Ab in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Alligator Bioscience Ab with additional patents listed. Browse our Agent directory for other possible listings. Page by